Key facts
- It has raised $25.0M; the latest was Later Stage VC ($25.0M) in Feb 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for BioMed Research
- ·The full record, as it builds
Funding rounds
No funding rounds for BioMed Research are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioMed Research
Operator of a healthcare startup intended for the treatment of chronic illnesses. The company focuses on advancing medical research and developing innovative treatments for chronic diseases, enabling healthcare professionals to develop new treatments for medical purposes.
- Sector
- Healthcare
- Ownership
- Privately Held (backing)
BioMed Research doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioMed Research shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioMed Research in its N-PORT filings yet. We sweep new filings monthly.